Related Experiment Video
Updated: Aug 30, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
The cyclin-dependent kinase 11(p46) isoform interacts with RanBPM
Monika Mikolajczyk1, Jiaqi Shi, Richard R Vaillancourt
1Department of Pathology, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.
Abstract:
We identified Ran-binding protein (RanBPM) as an interacting partner of the caspase-processed C-terminal domain of cyclin-dependent kinase 11 (CDK11(p46)) by using the yeast two-hybrid system. CDK11(p110) protein kinases are members of the cyclin-dependent kinase superfamily. During staurosporine-, Fas-, and tumor necrosis factor alpha-induced apoptosis caspase-processed activated CDK11(p46) is generated from larger CDK11(p110) isoforms. CDK11(p46) promotes apoptosis when it is ectopically expressed in human cells. However, the mechanism of signal transduction through CDK11(p46) is still unclear. In this study, we demonstrate that CDK11(p46) directly interacts with RanBPM in vitro and in human cells. RanBPM contains a conserved SPRY (repeats in splA and Ryr) domain and is localized both in the nucleus and cytoplasm. The SPRY domain of RanBPM is responsible for the association between CDK11(p46) and RanBPM. Furthermore, we show that CDK11(46) phosphorylates RanBPM.
Insights
We discovered that Ran-binding protein (RanBPM) interacts with cyclin-dependent kinase 11 (CDK11(p46)), a key player in apoptosis. This interaction reveals a new signaling pathway for CDK11(p46) in programmed cell death.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Cyclin-dependent kinase 11 (CDK11) exists as larger isoforms (CDK11(p110)) and a smaller, apoptosis-promoting form (CDK11(p46)) generated during programmed cell death.
- The precise signaling mechanisms of CDK11(p46) in apoptosis remain largely uncharacterized.
Purpose of the Study:
- To identify interacting partners of the caspase-processed CDK11(p46).
- To elucidate the molecular mechanisms underlying CDK11(p46)-mediated apoptosis signaling.
Main Methods:
- Yeast two-hybrid screening to identify protein-protein interactions.
- In vitro binding assays and studies in human cells to confirm interactions.
- Analysis of protein domains, specifically the SPRY domain of RanBPM.
- In vitro kinase assays to assess phosphorylation activity.
Main Results:
- Ran-binding protein (RanBPM) was identified as a direct interacting partner of CDK11(p46).
- The interaction between CDK11(p46) and RanBPM was confirmed both in vitro and within human cells.
- The SPRY domain of RanBPM is essential for its association with CDK11(p46).
- CDK11(p46) was demonstrated to phosphorylate RanBPM.
Conclusions:
- RanBPM is a novel binding partner for the apoptosis-associated kinase CDK11(p46).
- The interaction is mediated by the SPRY domain of RanBPM, suggesting a structural basis for the complex.
- CDK11(p46) possesses kinase activity towards RanBPM, indicating a potential regulatory mechanism within the apoptosis pathway.
Related Concept Videos
Positive Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
Negative Regulator Molecules
Anaphase Promoting Complex
Directionality of Nuclear Transport
